What is your surveillance protocol for patients with common variable immunodeficiency receiving chronic IVIG therapy?
Is there a target IgG level to aim for?
What should hematologists be aware of in monitoring these patients?
Answer from: at Academic Institution
No target IgG level per se- dose/interval should be titrated to clinical condition. In general, trough IgG on treatment should be higher than 500 mg/dL, or 500 mg/dL higher than baseline. Most patients will not be in optimal clinical condition (minimal fatigue, arthralgias, absence of chronic ...
Comments
at Berkshire Health Systems Agree. Rather than the specific level listen to th...
at NorthShore University HealthSystem-Metro Chicago Would you add a regular survey of skin as the occu...
Agree. Rather than the specific level listen to th...
Would you add a regular survey of skin as the occu...